140 results on '"Mikhailidis, Dimitri P."'
Search Results
2. Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia
3. Rationale for screening selected patients for asymptomatic carotid artery stenosis
4. Cardiovascular effects of sodium–glucose cotransporter 2 inhibitors: multiple actions
5. Adherence to statin treatment: an important issue in clinical practice
6. Should we consider ezetimibe to reach even lower LDL-C targets?
7. How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic
8. Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention
9. Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors
10. Risk of illness, hospitalization and death in a cohort of blood donors in Italy
11. The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!
12. Reaching hypertriglyceridemia goals
13. Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?
14. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review
15. Targeting cardiovascular risk: the impact of age, gender and compliance to treatment
16. Therapeutic options for statin-intolerant patients
17. Glycated hemoglobin A1c(HbA1c) and diabetes: a new era?
18. The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients
19. Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis
20. Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman
21. Ezetimibe and low density lipoprotein subfractions: an ongoing debate
22. Ezetimibe in diabetes: more than cholesterol lowering?
23. Statin-fibrate combination for mixed dyslipidaemia: a limited option?
24. Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?
25. Undertreatment of hypercholesterolemia
26. Role and significance of statins in the treatment of hypertensive patients
27. Statins and venous thromboembolism: a novel effect of statins?
28. JUPITER: major implications for vascular risk assessment
29. Statin discontinuation: an underestimated risk?
30. Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice study
31. Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study
32. Lipid abnormalities and cardiovascular risk in the elderly
33. C-reactive protein (CRP): more than just an innocent bystander?
34. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin
35. Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia
36. Metallothionein expression in the high-risk carotid atherosclerotic plaque
37. Shape of the Nations survey and attitudes to cardiometabolic risk
38. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia
39. Treating to target patients with primary hyperlipidaemia:comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)
40. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
41. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe
42. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions
43. The involvement of professional medical writers in medical publications
44. A review of the lipid-related effects of fluvastatin
45. Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study
46. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
47. Early vascular benefits of statin therapy
48. The Choice of Antihypertensive Drugs in Patients with Erectile Dysfunction
49. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
50. Beyond LDL-C – The Importance of Raising HDL-C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.